Second-generation antihistamines: The risk of ventricular arrhythmias
- 28 February 1999
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (2), 281-295
- https://doi.org/10.1016/s0149-2918(00)88286-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Dangers of non-sedating antihistaminesThe Lancet, 1997
- Dangers of non-sedating antihistaminesThe Lancet, 1997
- Risks of non-sedating antihistaminesThe Lancet, 1997
- Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea‐pigsClinical and Experimental Allergy, 1995
- Is QT interval prolongation harmful? A regulatory perspectiveThe American Journal of Cardiology, 1993
- Torsade de pointes induced by astemizole in a patient with prolongation of the QT intervalAmerican Heart Journal, 1993
- Torsades de pointes after terfenadine-itraconazole interaction.BMJ, 1993
- H1-receptor antagonist treatment of seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1990
- Torsades de pointes occurring in association with terfenadine useJAMA, 1990
- Diphenhydramine: Pharmacokinetics and Pharmacodynamics in Elderly Adults, Young Adults, and ChildrenThe Journal of Clinical Pharmacology, 1990